We are live on ! Find out more
ALDR

Alder Biopharmaceuticals
ALDR

Delisted

ALDR was delisted on the 21st of October, 2019.

Back to rankings

132 hedge funds and large institutions have $803M invested in Alder Biopharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 62 increasing their positions, 24 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

158% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 24

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

35% more capital invested

Capital invested by funds: $595M → $803M (+$208M)

22% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 23

3% more funds holding

Funds holding: 128 → 132 (+4)

22% less call options, than puts

Call options by funds: $1.86M | Put options by funds: $2.39M

Holders
132
Holders Change
+4
Holders Change %
+3.13%
% of All Funds
3.29%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
28
Increased
62
Reduced
24
Closed
23
Calls
$1.86M
Puts
$2.39M
Net Calls
-$532K
Net Calls Change
+$4.38M

Top Buyers

1
RG
Redmile Group
California
+$44.3M
2
State Street
State Street
Massachusetts
+$18.3M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$14.6M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$13.7M
5
PA
Pinnacle Associates
New York
+$12.6M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$22.7M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$14.7M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$13.8M
4
PHS
PFM Health Sciences
California
-$9.55M
5
AAMU
Amundi Asset Management US
Massachusetts
-$5.36M
Name Holding Trade Value Shares
Change 		Change in
Stake
Tudor Investment Corp
51
Tudor Investment Corp
Connecticut
$1.37M +$660K +63,311 +131%
Point72 Asset Management
52
Point72 Asset Management
Connecticut
$1.36M -$1.65M -158,654 -59%
ACM
53
Asymmetry Capital Management
California
$1.29M -$641K -61,524 -37%
American Century Companies
54
American Century Companies
Missouri
$1.26M +$122K +11,679 +13%
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$1.24M +$185K +17,790 +21%
SCA
56
Secor Capital Advisors
New York
$1.24M +$88.2K +8,459 +9%
HCMT
57
Highland Capital Management (Texas)
Texas
$1.23M +$1.04M +100,000 New
Swiss National Bank
58
Swiss National Bank
Switzerland
$1.19M +$323K +31,000 +47%
TA
59
Teachers Advisors
New York
$1.16M +$104K +9,993 +12%
ECM
60
Endurant Capital Management
California
$1.12M +$514K +49,300 +117%
ARTA
61
A.R.T. Advisors
New York
$1.1M +$936K +89,727 New
CS
62
Credit Suisse
Switzerland
$1.1M -$448K -43,013 -32%
MWNA
63
Marshall Wace North America
New York
$980K +$852K +81,681 New
USAA
64
United Services Automobile Association
Texas
$947K +$479K +45,970 +147%
UBS Group
65
UBS Group
Switzerland
$943K +$792K +76,003 +7,547%
Macquarie Group
66
Macquarie Group
Australia
$919K – – –
Baird Financial Group
67
Baird Financial Group
Wisconsin
$881K +$459K +43,996 +157%
RhumbLine Advisers
68
RhumbLine Advisers
Massachusetts
$874K +$103K +9,918 +16%
California Public Employees Retirement System
69
California Public Employees Retirement System
California
$815K – – –
AllianceBernstein
70
AllianceBernstein
Tennessee
$810K -$14.7M -1,412,476 -96%
PAI
71
Palo Alto Investors
California
$789K +$671K +64,400 New
Alyeska Investment Group
72
Alyeska Investment Group
Illinois
$752K +$640K +61,414 New
PCM
73
Prelude Capital Management
New York
$672K -$332K -31,873 -37%
New York State Common Retirement Fund
74
New York State Common Retirement Fund
New York
$625K – – –
Manulife (Manufacturers Life Insurance)
75
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$604K +$123K +11,783 +31%
1 2
3
4 5

ALDR Hedge Fund Activity: Q3 2017 in Review

132 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Alder Biopharmaceuticals (ALDR) for Q3 2017, worth a combined $803M — up 35% from $595M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ALDR positions and 23 closed out — a net gain of 5 holders — while 62 added to existing stakes and 24 trimmed.

The largest buyer was Redmile Group, adding an estimated $44.3M. The largest seller was Janus Henderson Group, cutting an estimated $22.7M.

  • 132 institutional investors held Alder Biopharmaceuticals (ALDR) as of Q3 2017, up from 128 in Q2 2017.
  • Funds reported $803M of Alder Biopharmaceuticals stock for Q3 2017, up 35% quarter-over-quarter.
  • 28 funds opened new Alder Biopharmaceuticals positions in Q3 2017 and 23 closed out, a net change of +5 holders.
  • The largest Alder Biopharmaceuticals buyer in Q3 2017 was Redmile Group, an estimated $44.3M added.
  • The largest Alder Biopharmaceuticals seller in Q3 2017 was Janus Henderson Group, an estimated $22.7M sold.

Based on aggregated 13F filings for Q3 2017.